Cargando…
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disease and its diagnosis has classically been based on clinical symptoms. Recently, a biological rather than a syndromic definition of the disease has been proposed that is based on biomarkers that reflect neuropathological changes. In A...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920596/ https://www.ncbi.nlm.nih.gov/pubmed/31897088 http://dx.doi.org/10.1177/1756286419888819 |